Bookrunners Piper Jaffray and Leerink Swann assisted with offering
By Devika Patel
Knoxville, Tenn., July 24 - Anthera Pharmaceuticals, Inc. said it settled a $37.95 million registered public sale of stock. The deal was announced July 18 and priced for $33 million with a $4.95 million greenshoe on July 19.
The company sold 37.95 million common shares. The price per share of $1.00 is a 24.81% discount to $1.33, the July 18 closing share price.
Of the shares, 4.95 million were part of the fully exercised greenshoe.
Piper Jaffray & Co. and Leerink Swann LLC were the joint bookrunning managers. Canaccord Genuity was the lead manager and Summer Street Research Partners was the co-manager.
Proceeds will be used for general corporate purposes.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $37.95 million (including $4.95 million greenshoe)
|
| Shares: | 37.95 million
|
| Price: | $1.00
|
| Warrants: | No
|
| Managers: | Piper Jaffray & Co. and Leerink Swann LLC (bookrunners); Canaccord Genuity (lead) and Summer Street Research Partners (co-manager)
|
| Announcement date: | July 18
|
| Pricing date: | July 19
|
| Settlement date: | July 24
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $1.33 at close July 18
|
| Market capitalization: | $43.96 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
